Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: A Study of Disitamab Vedotin Combined With Tislelizumab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in HER2-Low Advanced Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 3]
Phase 3 clinical trial update evaluating disitamab vedotin plus tislelizumab and chemotherapy versus tislelizumab and chemotherapy in HER2-l…
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis
A clinical trial is evaluating a Raman spectroscopy-based deep learning model for early cancer diagnosis; recruitment is ongoing. The study …
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Randomized Phase II Trial Evaluating DFS in The Absence of an Adjuvant Component of Perioperative Chemotherapy in Patients With Gastric Cancer [Phase 2]
A randomized Phase II trial in gastric cancer evaluates disease-free survival when the adjuvant component of perioperative chemotherapy is o…
-
CLINICAL_TRIALS trial_result · 2025-04-23Clinical Trial Update: Potential Advantages of Robotic Total Gastrectomy in Advanced Middle-Upper Gastric Cancer: A Multicenter Propensity Score Matching Analysis
A multicenter propensity score-matched analysis assesses the potential advantages of robotic total gastrectomy for advanced middle-upper gas…
-
CLINICAL_TRIALS research · 2025-04-23Clinical Trial Update: Real-World Study on Nano-Crystalline Megestrol Acetate for Cachexia in TKI-Treated Advanced Digestive Tumors
A real-world study evaluating nano-crystalline megestrol acetate for cachexia in patients with advanced digestive tumors is currently recrui…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors [EARLY_Phase 1]
An early-phase trial evaluating CDH17-targeted CAR-T cell therapy for advanced malignant solid tumors, including biliary tract cancer, color…
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer [Phase 2, Phase 3]
This clinical trial update reports the completion of a Phase 2/3 study evaluating a four-drug combination (margetuximab, retifanlimab, tebot…
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors [Phase 1]
This clinical trial update reports the completion of a Phase 1 study of CEA-targeted CAR-T therapy for CEA-positive advanced solid tumors, i…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Neoadjuvant Apatinib Combined With Sintilimab and Perioperative SOX Versus Neoadjuvant Sintilimab Combined With Perioperative SOX for Intestinal Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 3]
This Phase 3 clinical trial assesses whether adding apatinib to sintilimab and perioperative SOX improves outcomes versus sintilimab plus pe…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Defining Benchmarks for Gastric Cancer Patients Underwent Minimal Invasive Gastrectomy
This clinical trial update from Fujian Medical University aims to define benchmarks for gastric cancer patients who have undergone minimally…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Wet Heparinized Suction for Abdominal Cancer [NA]
This clinical trial update describes an investigative study of wet heparinized suction for abdominal cancers, currently not yet recruiting.
-
CLINICAL_TRIALS research · 2025-04-18Clinical Trial Update: Clinical Study of Double-Endoscopic Combined With Minimally Invasive Treatment for Early Gastric Cancer at Clinical Stage T1b [NA]
A clinical trial evaluating a double-endoscopic combined with minimally invasive treatment approach for early gastric cancer at clinical sta…
-
CLINICAL_TRIALS research · 2025-04-18Clinical Trial Update: Validation of a Molecular Test for Risk-stratification of Patients With High-risk Intestinal Metaplasia (GCEP2 Study)
This clinical trial update describes the GCEP2 study, which aims to validate a molecular test for risk stratification in patients with high-…
-
CLINICAL_TRIALS research · 2025-04-18Clinical Trial Update: Evaluation of Efficacy and Safety De-escalation Versus Standard Adjuvant Chemotherapy in Patients With Low Risk Localized Gastroesophageal Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating de-escalation versus standard adjuvant chemotherapy in patients with low-risk localized gastroesophageal c…
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: Perioperative mFOLFOX-6 in Locally Advanced Gastric Cancer [Phase 2]
Phase 2 trial evaluating perioperative mFOLFOX-6 for locally advanced gastric cancer has completed. The update provides trial status and con…
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Phase II Trial of Iparomlimab/Tuvonralimab (QL1706) + XELOX in HER2-Negative, Low PD-L1 G/GEJ Adenocarcinoma [Phase 2]
Phase II trial evaluating Iparomlimab/Tuvonralimab (QL1706) with XELOX in HER2-negative, low PD-L1 expressing unresectable or metastatic gas…
-
CLINICAL_TRIALS trial_result · 2025-04-16Clinical Trial Update: Lenvatinib and Pembrolizumab Simultaneous Combination Study [Phase 2]
Phase 2 study evaluating the combination of lenvatinib and pembrolizumab in advanced gastric cancer has completed, with results posted on 20…
-
CLINICAL_TRIALS trial_result · 2025-04-16Clinical Trial Update: A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer [Phase 1, Phase 2]
A completed Phase 1/2 study evaluated IMU-131 (HER-Vaxx) in combination with chemotherapy versus chemotherapy alone in HER2-positive advance…
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: The Effect of Different Digestive Tract Reconstruction Methods on Postoperative Quality of Life After Proximal Gastrectomy
This clinical trial investigates how different digestive tract reconstruction methods after proximal gastrectomy affect patients' postoperat…
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery [NA]
This clinical trial update notes a prospective evaluation of the Cornerstone Robotics Sentire Surgical System in major gastrointestinal and …
-
CLINICAL_TRIALS trial_result · 2025-04-13Clinical Trial Update: Effect of Smart Phone App-based Human Coaching Program in Gastrectomized Patients [NA]
This document reports the completed status of a clinical trial evaluating a smartphone app-based human coaching program for patients who hav…
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Gastric Cancer' Textbook Oncological Outcome and Tumor Board Performance
This clinical trial aims to evaluate oncological outcomes in gastric cancer and the performance of tumor boards. The study is currently recr…
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: A Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer Patients With Peritoneal Metastasis [Phase 2]
A Phase 2 clinical trial is evaluating a combination of systemic chemotherapy and immune checkpoint inhibitors with hyperthermic intraperito…
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Association of Nutritional Status With Immune Checkpoint Inhibitor Efficacy in Metastatic Metastatic Esophagogastric Cancer.
A clinical trial update examines whether nutritional status influences the efficacy of immune checkpoint inhibitors in metastatic esophagoga…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Phase II Study of Neoadjuvant Immune Checkpoint Inhibitor in Patients With Resectable Gastrointestinal Cancers [Phase 2]
Phase II neoadjuvant immune checkpoint inhibitor trial in patients with resectable gastric, esophageal, or liver cancer; currently active bu…